Literature DB >> 23526818

Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

Steven M Brunelli1, Joshua J Gagne, Krista F Huybrechts, Shirley V Wang, Amanda R Patrick, Kenneth J Rothman, John D Seeger.   

Abstract

PURPOSE: When using claims data, dichotomous covariates (C) are often assumed to be absent unless a claim for the condition is observed. When available historical data differs among subjects, investigators must choose between using all available historical data versus data from a fixed window to assess C. Our purpose was to compare estimation under these two approaches.
METHODS: We simulated cohorts of 20,000 subjects with dichotomous variables representing exposure (E), outcome (D), and a single time-invariant C, as well as varying availability of historical data. C was operationally defined under each paradigm and used to estimate the adjusted risk ratio of E on D via Mantel-Haenszel methods.
RESULTS: In the base case scenario, less bias and lower mean square error were observed using all available information compared with a fixed window; differences were magnified at higher modeled confounder strength. Upon introduction of an unmeasured covariate (F), the all-available approach remained less biased in most circumstances and rendered estimates that better approximated those that were adjusted for the true (modeled) value of C in all instances.
CONCLUSIONS: In most instances considered, operationally defining time-invariant dichotomous C based on all available historical data, rather than on data observed over a commonly shared fixed historical window, results in less biased estimates.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23526818      PMCID: PMC3653131          DOI: 10.1002/pds.3434

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  14 in total

1.  Comparing the effects of continuous and discrete covariate mismeasurement, with emphasis on the dichotomization of mismeasured predictors.

Authors:  Paul Gustafson; D Le Nhu
Journal:  Biometrics       Date:  2002-12       Impact factor: 2.571

2.  Selection of controls in case-control studies. I. Principles.

Authors:  S Wacholder; J K McLaughlin; D T Silverman; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

3.  Correlated nondifferential misclassifications of disease and exposure: application to a cross-sectional study of the relation between handedness and immune disorders.

Authors:  M Chavance; G Dellatolas; J Lellouch
Journal:  Int J Epidemiol       Date:  1992-06       Impact factor: 7.196

4.  The accuracy of Medicare's hospital claims data: progress has been made, but problems remain.

Authors:  E S Fisher; F S Whaley; W M Krushat; D J Malenka; C Fleming; J A Baron; D C Hsia
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

5.  Differential misclassification arising from nondifferential errors in exposure measurement.

Authors:  K M Flegal; P M Keyl; F J Nieto
Journal:  Am J Epidemiol       Date:  1991-11-15       Impact factor: 4.897

6.  Misclassification of covariates.

Authors:  A M Walker; S F Lanes
Journal:  Stat Med       Date:  1991-08       Impact factor: 2.373

7.  Estimating and correcting for confounder misclassification.

Authors:  D A Savitz; A E Barón
Journal:  Am J Epidemiol       Date:  1989-05       Impact factor: 4.897

8.  Varied forms of bias due to nondifferential error in measuring exposure.

Authors:  H Brenner; D Loomis
Journal:  Epidemiology       Date:  1994-09       Impact factor: 4.822

9.  The effect of misclassification in the presence of covariates.

Authors:  S Greenland
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

10.  Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database.

Authors:  Vicky Tagalakis; Susan R Kahn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-30       Impact factor: 2.890

View more
  33 in total

1.  Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012.

Authors:  Mitchell M Conover; Jennifer O Howell; Jennifer M Wu; Alan C Kinlaw; Nabarun Dasgupta; Michele Jonsson Funk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-03-31       Impact factor: 2.890

2.  Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.

Authors:  Rebecca B Naumann; Andrew W Roberts; Stephen W Marshall; Asheley C Skinner
Journal:  Med Care       Date:  2019-03       Impact factor: 2.983

3.  Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Authors:  Glenn M Chertow; Jiannong Liu; Keri L Monda; David T Gilbertson; M Alan Brookhart; Anne C Beaubrun; Wolfgang C Winkelmayer; Allan Pollock; Charles A Herzog; Akhtar Ashfaq; Til Sturmer; Kenneth J Rothman; Brian D Bradbury; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2016-02-25       Impact factor: 10.121

4.  Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches.

Authors:  Mitchell M Conover; Til Stürmer; Charles Poole; Robert J Glynn; Ross J Simpson; Virginia Pate; Michele Jonsson Funk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-04-14       Impact factor: 2.890

5.  Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient.

Authors:  Andrew W Roberts; Stacie B Dusetzina; Joel F Farley
Journal:  J Comp Eff Res       Date:  2015-01       Impact factor: 1.744

6.  Restrictive reimbursement policies: bias implications for claims-based drug safety studies.

Authors:  Joshua J Gagne
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

7.  Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk.

Authors:  Susan M Shortreed; Eric Johnson; Carolyn M Rutter; Aruna Kamineni; Karen J Wernli; Jessica Chubak
Journal:  Obs Stud       Date:  2016-09-26

8.  Methodological considerations when analysing and interpreting real-world data.

Authors:  Til Stürmer; Tiansheng Wang; Yvonne M Golightly; Alex Keil; Jennifer L Lund; Michele Jonsson Funk
Journal:  Rheumatology (Oxford)       Date:  2020-01-01       Impact factor: 7.580

9.  Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.

Authors:  Tara I Chang; Maria E Montez-Rath; Thomas T Tsai; Mark A Hlatky; Wolfgang C Winkelmayer
Journal:  J Am Coll Cardiol       Date:  2016-03-29       Impact factor: 24.094

10.  Health Care Utilization and Comorbidity History of North Carolina Medicaid Beneficiaries in a Controlled Substance "Lock-in" Program.

Authors:  Rebecca B Naumann; Stephen W Marshall; Jennifer L Lund; Asheley C Skinner; Christopher Ringwalt; Nisha C Gottfredson
Journal:  N C Med J       Date:  2019 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.